An important question.
I've been asked many times about the steps to move a drug forward into and through clinical trials.
Here's a quick video where I describe how I've spent my time since yesterday's video. And it is only part of the list!
Share This
|
Sign up at: ParkinsonsDisease.blog |
About Jonathan Sackner-Bernstein, MD
Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD.
Dr. S-B’s Linkedin page
RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.